ArticleFrontiers in cardiovascular medicine2026
Transient cortical blindness following coronary angiography: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transient cortical blindness is an extremely rare and reversible neurological complication following angiographic procedures and is thought to be related to transient dysfunction of the occipital cortex. We report a 62-year-old woman with hypertension who underwent coronary angiography using 40 mL of the iso-osmolar contrast medium iodixanol. No significant coronary stenosis was identified. Approximately 10 min after contrast medium injection, she developed rapidly progressive bilateral visual loss, which progressed to complete blindness, accompanied by dizziness but without other neurological deficits. She remained alert, with preserved pupillary light reflexes and a normal ophthalmologic examination. Emergent cranial CT and MRI, performed approximately 25 min after contrast injection, showed no evidence of acute infarction or hemorrhage. Based on the close temporal association with contrast exposure and the exclusion of other causes, contrast-induced transient cortical blindness was considered. With supportive treatment, her vision gradually recovered and returned nearly to normal within one week. No abnormalities were observed at the 3-month follow-up. Conclusion: Even iso-osmolar contrast agents such as iodixanol may induce transient cortical blindness. Further studies are needed to clarify the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.